STING Membrane Prevents Post‐Surgery Tissue Adhesion and Tumor Recurrence of Colorectal Cancer
Source abstract
Abstract
Abstract Surgery is the standard treatment regimen for resectable colorectal cancer (CRC). However, it is very hard to completely remove all cancer cells in clinical practice, leading to the high recurrence rates of the disease. Moreover, the post‐surgery tissue adhesion greatly prevents the possibility of reoperation, significantly limiting the long‐term surviving of CRC patients. To overcome CRC recurrence and avoid the post‐surgery tissue adhesion, this work develops a novel stimulator of interferon genes “STING” membrane based on the coaxial electrospinning technology and hyaluronic acid modification. A reactive oxygen species responsive prodrug of gambogic acid (GB) and a potent STING agonist (CDN) are coloaded in the core–shell structure of the membrane, which endows the loaded drug with sustained and sequential release patterns. The localized delivery of GB and CDN can selectively induce efficient immunogenic cell death of cancer cells and then evoke the systemic anticancer immunity by activating the Cyclic GMP‐AMP (cGAMP) synthase/STING pathway. As‐designed “STING” membrane not only safely prevents tumor recurrence through the synergistic chemoimmunotherapy but also efficiently avoids the post‐surgery tissue adhesion, facilitating the clinical intervention of CRC.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: interferon and immune responses · Immune Cell Function and Interaction · Glycosylation and Glycoproteins Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The State Key Laboratory of Organic‐inorganic Composites Beijing Laboratory of Biomedical Materials Key Laboratory of Biomedical Materials of Natural Macromolecules (Ministry of Education) College of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 China
Department of Urology China‐Japan Friendship Hospitals Beijing 100029 China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (42)
Show source-provided references
1. 10.1016/j.annonc.2020.06.02210.1016/j.annonc.2020.06.022 ↗
2. 10.1007/s11912-011-0157-010.1007/s11912-011-0157-0 ↗
3. 10.1097/00000658-200005000-0001510.1097/00000658-200005000-00015 ↗
4. 10.1080/17425247.2021.188951210.1080/17425247.2021.1889512 ↗
5. 10.1002/adhm.20220267210.1002/adhm.202202672 ↗
6. 10.1038/nmat470710.1038/nmat4707 ↗
7. 10.1038/nrclinonc.2009.21710.1038/nrclinonc.2009.217 ↗
8. 10.1016/j.addr.2009.07.01910.1016/j.addr.2009.07.019 ↗
9. 10.1002/adhm.20180121310.1002/adhm.201801213 ↗
10. 10.1016/S0169-409X(02)00090-X10.1016/S0169-409X(02)00090-X ↗
11. 10.1002/jso.2106110.1002/jso.21061 ↗
12. 10.1038/s41575-019-0126-x10.1038/s41575-019-0126-x ↗
13. 10.1016/j.jconrel.2023.04.01110.1016/j.jconrel.2023.04.011 ↗
14. 10.1126/sciadv.aaw607110.1126/sciadv.aaw6071 ↗
15. 10.1016/j.jconrel.2019.06.01710.1016/j.jconrel.2019.06.017 ↗
16. 10.1038/nri392110.1038/nri3921 ↗
17. 10.1002/med.2164910.1002/med.21649 ↗
18. 10.1126/sciimmunol.abn661210.1126/sciimmunol.abn6612 ↗
19. 10.1038/cr.2016.14910.1038/cr.2016.149 ↗
20. 10.1016/j.molcel.2020.07.02610.1016/j.molcel.2020.07.026 ↗
21. 10.1016/j.jconrel.2020.11.01710.1016/j.jconrel.2020.11.017 ↗
22. 10.1002/mabi.20080001110.1002/mabi.200800011 ↗
23. 10.1038/nrc306410.1038/nrc3064 ↗
24. 10.1038/nrc380310.1038/nrc3803 ↗
25. 10.1016/j.polymdegradstab.2018.02.00210.1016/j.polymdegradstab.2018.02.002 ↗
26. 10.1016/j.snb.2021.12987810.1016/j.snb.2021.129878 ↗
27. 10.1016/j.semradonc.2004.04.00810.1016/j.semradonc.2004.04.008 ↗
28. 10.1096/fasebj.2021.35.S1.0340410.1096/fasebj.2021.35.S1.03404 ↗
29. 10.1007/s00432-021-03879-x10.1007/s00432-021-03879-x ↗
30. 10.1016/j.biomaterials.2021.12130510.1016/j.biomaterials.2021.121305 ↗
31. 10.1126/science.211331410.1126/science.2113314 ↗
32. 10.1007/978-981-32-9717-3_110.1007/978-981-32-9717-3_1 ↗
33. 10.1016/j.immuni.2013.07.00410.1016/j.immuni.2013.07.004 ↗
34. 10.1002/ijc.3215110.1002/ijc.32151 ↗
35. 10.1093/molehr/gap10610.1093/molehr/gap106 ↗
36. 10.1021/acsnano.1c0670710.1021/acsnano.1c06707 ↗
37. 10.1111/cas.1406910.1111/cas.14069 ↗
38. 10.1007/s10549-013-2684-x10.1007/s10549-013-2684-x ↗
39. 10.1016/S0889-1591(02)00063-610.1016/S0889-1591(02)00063-6 ↗
40. 10.1021/acsnano.0c0711310.1021/acsnano.0c07113 ↗
41. 10.1002/ptr.635010.1002/ptr.6350 ↗
42. 10.1126/sciimmunol.add115310.1126/sciimmunol.add1153 ↗